Rennova Health Inc Revenue Growth Rates (CLRX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Rennova Health Inc   (CLRX)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

CLRX's Revenue Growth by Quarter and Year

Rennova Health Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CLRX Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December 3.84
3rd Quarter September 3.54
2nd Quarter June 6.39
1st Quarter March 4.92
FY 18.69

CLRXs Annual Revenue
Rennova Health Inc 's Revenue in the fiscal year 2023 $ 18.69 millions
Rennova Health Inc 's Revenue in the fiscal year 2022 $ 13.04 millions
Rennova Health Inc 's Revenue in the fiscal year 2021 $ 3.22 millions
Rennova Health Inc 's Revenue in the fiscal year 2020 $ 7.20 millions
Rennova Health Inc 's Revenue in the fiscal year 2019 $ 15.99 millions




CLRX Revenue fourth quarter 2023 Y/Y Growth Comment
Rennova Health Inc reported fall in Revenue in the fourth quarter 2023 by -29.62% to $ 3.84 millions, from the same quarter in 2022.
The drop in the fourth quarter 2023 Rennova Health Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 1843.7%.

Looking into fourth quarter 2023 results within Healthcare Facilities industry 43 other companies have achieved higher Revenue growth. While Rennova Health Inc ' s Revenue drop of -29.62% ranks overall at the positon no. 3574 in the fourth quarter 2023.


CLRX Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter December -29.62 % 181.44 % 44.78 % -52.98 %
3rd Quarter September 25.09 % 180.2 % -48.21 % -50.26 %
2nd Quarter June 77.01 % 288.17 % -55.07 % -49.01 %
1st Quarter March 331.58 % - - -64.55 %
FY   43.35 % 303.72 % -55.14 % -

Financial Statements
Rennova Health Inc 's fourth quarter 2023 Revenue $ 3.84 millions CLRX's Income Statement
Rennova Health Inc 's fourth quarter 2022 Revenue $ 5.46 millions Quarterly CLRX's Income Statement


CLRX Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter December 8.55 % 92.93 % 92.08 % -31.28 %
3rd Quarter September -44.6 % -21.61 % 8.6 % -5.8 %
2nd Quarter June 29.88 % 216.67 % - 12.5 %
1st Quarter March -9.89 % -41.24 % - -35.44 %
FY (Year on Year)   43.35 % 303.72 % -55.14 % -


Back to CLRX Growth rate Comparisons >> Back to CLRX Growth rate Comparisons >>


Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #44
Healthcare Sector #509
Overall #3574

Revenue Y/Y Growth Statistics
High Average Low
59434.16 % 1843.7 % -99.96 %
(Dec 31 2015)   (Jun 30 2017)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #44
Healthcare Sector #509
Overall #3574
Revenue Y/Y Growth Statistics
High Average Low
59434.16 % 1843.7 % -99.96 %
(Dec 31 2015)   (Jun 30 2017)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Rennova Health Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
48143.19 % 1380 % -100 %
(Dec 31 2015)  


CLRX's IV. Quarter Q/Q Revenue Comment
Rennova Health Inc achieved in the IV. Quarter 2023 below company average Revenue increase of 8.55% quarter on quarter, to $ 3.84 millions.

Within Healthcare Facilities industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Rennova Health Inc 's Revenue growth quarter on quarter, overall rank is 1061.


Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #6
Healthcare Sector #245
Overall #1061
Revenue Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #6
Healthcare Sector #245
Overall #1061
Revenue Q/Q Growth Statistics
High Average Low
48143.19 % 1380 % -100 %
(Dec 31 2015)  


CLRX's IV. Quarter Q/Q Revenue Comment
Rennova Health Inc achieved in the IV. Quarter 2023 below company average Revenue increase of 8.55% quarter on quarter, to $ 3.84 millions.

Within Healthcare Facilities industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Rennova Health Inc 's Revenue growth quarter on quarter, overall rank is 1061.


Rennova Health Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 18.69 $ 20.30 $ 19.59 $ 16.81 $ 13.04
Y / Y Revenue Growth (TTM) 43.34 % 113.44 % 154.54 % 234.87 % 304.36 %
Year on Year Revenue Growth Overall Ranking # 69 # 200 # 3175 # 2944 # 0
Seqeuential Revenue Change (TTM) -7.96 % 3.64 % 16.56 % 28.93 % 37.05 %
Seq. Revenue Growth (TTM) Overall Ranking # 445 # 369 # 828 # 2788 # 0


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2023 period, Rennova Health Inc 's cumulative twelve months Revenue were $ 19 millions, company would post below average annual Revenue growth of 37.05% year on year, if the fiscal year would end at Dec 31 2023.
A slow-down in the Rennova Health Inc 's Revenue growth from the 3.54% growth in Sep 30 2023.

Among companies within the Healthcare sector 20 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 69, from total ranking in previous quarter at 200.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 5
Healthcare Sector # 21
Overall # 69

Revenue TTM Y/Y Growth Statistics
High Average Low
13478.34 %
 1292.62 %
-96.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 126
S&P 500 # 445
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2023 period, Rennova Health Inc 's cumulative twelve months Revenue were $ 19 millions, company would post below average annual Revenue growth of -96.09% year on year, if the fiscal year would end at Dec 31 2023.
A slow-down in the Rennova Health Inc 's Revenue growth from the 3.54% growth in Sep 30 2023.

Among companies within the Healthcare sector 20 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 69, from total ranking in previous quarter at 200.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 5
Healthcare Sector # 21
Overall # 69

Revenue TTM Y/Y Growth Statistics
High Average Low
13478.34 %
1292.62 %
-96.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 126
S&P 500 # 445




Other Revenue Growth
Healthcare Facilities Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CLRX's Revenue Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Healthcare Services Group Inc -0.04%$ -0.042 millions
Integra Lifesciences Holdings Corp-0.25%$ -0.247 millions
Nrc Health-0.37%$ -0.375 millions
Skinhealth Systems Inc -0.63%$ -0.633 millions
3m Company-0.82%$ -0.817 millions
Enhabit Inc -0.95%$ -0.950 millions
Viatris Inc -1.00%$ -0.998 millions
Aspira Women s Health inc -1.07%$ -1.068 millions
Supernus Pharmaceuticals inc -1.80%$ -1.801 millions
Opko Health Inc -1.85%$ -1.853 millions
Quest Diagnostics Inc-1.93%$ -1.929 millions
Koru Medical Systems Inc -2.16%$ -2.161 millions
Envista Holdings Corporation-2.30%$ -2.300 millions
Ideaya Biosciences Inc -2.46%$ -2.461 millions
Zynex inc -3.11%$ -3.114 millions
Shl Telemedicine Ltd-3.26%$ -3.259 millions
Pediatrix Medical Group Inc -3.39%$ -3.386 millions
Baxter International Inc -3.55%$ -3.550 millions
Caribou Biosciences Inc -3.63%$ -3.629 millions
Gilead Sciences Inc -3.72%$ -3.722 millions
Lifevantage Corp-3.92%$ -3.921 millions
Avantor Inc -4.02%$ -4.022 millions
Sensus Healthcare Inc -4.11%$ -4.106 millions
Outset Medical Inc -4.17%$ -4.168 millions
Journey Medical Corp-4.44%$ -4.441 millions
Escalon Medical Corp -4.53%$ -4.533 millions
Waters Corporation-4.55%$ -4.547 millions
Inovio Pharmaceuticals Inc -4.55%$ -4.553 millions
Biolase Inc -4.68%$ -4.683 millions
American Shared Hospital Services-4.73%$ -4.725 millions


About Rennova Health Inc Revenue Growth Rates (CLRX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Rennova Health Inc (CIK 931059).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001493152-25-006522
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Rennova Health Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.